Authors: Garcia-Carbonero, R Mayordomo, JI Tornamira, MV Lopez-Brea, M Rueda, A Guillem, V Arcediano, A Yubero, A Ribera, F Gomez, C Tres, A Perez-Gracia, JL Lumbreras, C Hornedo, J Cortes-Funes, H Paz-Ares, L

Citation: R. Garcia-carbonero et al., Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial, J NAT CANC, 93(1), 2001, pp. 31-38

Authors: Bellmunt, J Guillem, V Paz-Ares, L Gonzalez-Larriba, JL Carles, J Albanell, J Tabernero, JM Cortes-Funes, H Baselga, J

Citation: J. Bellmunt et al., Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer, EUR J CANC, 36, 2000, pp. S17-S25

Authors: Gonzalez-Larriba, JL Serrano, S Alvarez-Mon, M Camacho, F Casado, MA Diaz-Perez, JL Diaz-Rubio, E Fosbrook, L Guillem, V Lopez-Lopez, JJ Moreno-Nogueira, JA Toribio, J

Citation: Jl. Gonzalez-larriba et al., Cost-effectiveness analysis of interferon as adjuvant therapy in high-riskmelanoma patients in Spain, EUR J CANC, 36(18), 2000, pp. 2344-2352

Authors: Bellmunt, J Guillem, V Paz-Ares, L Gonzalez-Larriba, JL Carles, J Batiste-Alentorn, E Saenz, A Lopez-Brea, M Font, A Nogue, M Bastus, R Climent, MA de la Cruz, JJ Albanell, J Banus, JM Gallardo, E Diaz-Rubio, E Cortes-Funes, H Baselga, J

Citation: J. Bellmunt et al., Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium, J CL ONCOL, 18(18), 2000, pp. 3247-3255

Authors: Colomer, R Llombart, A Lluch, A Ojeda, B Barnadas, A Caranana, V Fernandez, Y De Paz, L Guillem, V Alonso, S

Citation: R. Colomer et al., Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial, SEMIN ONCOL, 27(1), 2000, pp. 20-24